ClinicalTrialsFinder

Refractory T-Cell Prolymphocytic Leukemia Clinical Trials in Houston, Texas

1 recruitingHouston, Texas

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Phase Ib/II Trial of Cladribine/Ruxolitinib/Venetoclax in Patients With Relapsed/Refractory T-cell Prolymphocytic Leukemia

T-cell Prolymphocytic LeukemiaRefractory T-Cell Prolymphocytic Leukemia
M.D. Anderson Cancer Center36 enrolled1 locationNCT07311746